Treatment updates in myotonic disorders
{"Myotonia":[0],"is":[1,9,34,111,140,158],"delayed":[2,62],"muscle":[3,16,24],"relaxation":[4],"after":[5],"forceful":[6],"contraction.":[7],"It":[8,18,77,110],"due":[10],"to":[11,48,65,96,102],"hyperexcitability":[12],"of":[13,179,202],"the":[14,200],"skeletal":[15,23],"membrane.":[17],"can":[19,59,78,123,141,152],"arise":[20],"from":[21,61],"primary":[22],"ion":[25,50],"channel":[26,51],"dysfunction,":[27],"involving":[28],"chloride":[29],"or":[30,101],"sodium":[31],"channels,":[32],"but":[33],"also":[35,79],"a":[36,66,81,112,118,146],"prominent":[37],"clinical":[38,180,210],"feature":[39],"in":[40,125,175,199],"myotonic":[41,188,203],"dystrophies":[42],"where":[43],"altered":[44],"RNA":[45],"splicing":[46],"leads":[47],"secondary":[49],"dysregulation":[52],"amongst":[53],"other":[54],"systemic":[55],"manifestations.":[56],"Clinically,":[57],"myotonia":[58,135,170],"range":[60],"eye":[63],"opening":[64],"disabling":[67],"symptom":[68,113],"causing":[69],"impaired":[70],"mobility,":[71],"functional":[72],"difficulty":[73],"and":[74,130,165,171,205],"sometimes":[75],"pain.":[76],"be":[80,142,153],"\\"hidden":[82],"disability\\"":[83],"with":[84,150],"many":[85,163],"patients":[86],"feeling":[87],"socially":[88],"embarrassed":[89],"by":[90],"\\"looking":[91],"healthy\\",":[92],"yet":[93],"being":[94],"unable":[95],"do":[97,103],"everyday":[98],"physical":[99],"tasks":[100],"them":[104],"as":[105,107],"effortlessly":[106],"their":[108],"peers.":[109],"that":[114],"almost":[115],"always":[116],"indicates":[117],"genetic":[119,147],"diagnosis,":[120],"although":[121],"it":[122,139,151],"occur":[124],"acquired":[126],"conditions,":[127],"including":[128],"metabolic":[129],"drug-induced":[131],"causes.":[132],"To":[133,144],"experience":[134],"without":[136],"knowing":[137],"what":[138],"baffling.":[143],"receive":[145],"diagnosis":[148],"associated":[149],"life":[154],"changing.":[155],"Although":[156],"there":[157,161],"no":[159],"cure,":[160],"are":[162,174],"effective":[164],"available":[166],"symptomatic":[167],"treatments":[168],"for":[169,182,187],"currently":[172],"we":[173,195],"an":[176],"exciting":[177],"era":[178],"trials":[181],"new":[183],"molecular":[184],"disease-modifying":[185],"therapies":[186],"dystrophy":[189],"type":[190],"1.":[191],"In":[192],"this":[193],"review,":[194],"consider":[196],"recent":[197],"developments":[198],"treatment":[201],"disorders":[204],"how":[206],"they":[207],"may":[208],"change":[209],"practice.":[211]}
Authors
- Karlien Mul (ORCID: https://orcid.org/0000-0001-8487-9478)
- Mark Specterman (ORCID: https://orcid.org/0000-0001-8533-2140)
- Emma Matthews (ORCID: https://orcid.org/0000-0002-3810-306X)
Institutions
- Radboud University Nijmegen (NL)
- St George's, University of London (GB)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1007/s00415-026-14073-9
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00